Becton, Dickinson and Company stock page - price, fundamentals, dividends - iOCharts

BDX

261.95
-0.72 (-0.27%)
Becton, Dickinson and Company (NYSE, USD)
Healthcare >
Medical Instruments & Supplies
Market cap
76.18B
Ent value
102.54B
Price/Sales
4.18
Price/Book
3.07
Div yield
1.27%
Div growth
5.40%
Growth years
49
FCF payout
29.87%
Trailing P/E
47.61
Forward P/E
20.01
PEG
9.52
EPS growth
-8.90%
1 year return
14.99%
3 year return
0.61%
5 year return
8.28%
10 year return
13.11%
Last updated: 2021-09-17

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open262.00
Daily high262.90
Daily low260.43
Daily Volume2.47M
All-time high285.99
1y analyst estimate278.40
Beta0.77
EPS (TTM)5.51
Dividend per share3.32
Ex-div date8 Sep 2021
Next earnings date-

Downside potential

Loading...
Downside potential data
BDXS&P500
Current price drop from All-time high-8.41%-2.60%
Highest price drop-52.27%-56.47%
Date of highest drop26 Sep 20009 Mar 2009
Avg drop from high-11.57%-11.48%
Avg time to new high17 days12 days
Max time to new high1331 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share3.32
Dividend yield1.27%
Payout frequencyQuarterly
Maximum yield1.79%
Average yield1.36%
Minimum yield1.10%
Discount to avg yield-7.46%
Upside potential-6.94%
Yield as % of max yield70.66%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.27%
Current yield distribution71.19%
Yield at 100% (Min)1.10%
Yield at 90%1.21%
Yield at 80%1.24%
Yield at 50% (Median)1.33%
Yield at 20%1.47%
Yield at 10%1.60%
Yield at 0% (Max)1.79%

Dividend per share

Loading...
Dividend per share data
Years of growth49 years
CCC statusDividend Champion
Dividend per share3.32
Payout frequencyQuarterly
Ex-div date8 Sep 2021
EPS (TTM)5.51
EPS (1y forward)13.09
EPS growth (5y)-8.90%
EPS growth (5y forward)5.00%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BDXS&P500
DGR MR5.06%7.68%
DGR TTM5.06%-2.66%
DGR 3 years2.87%5.82%
DGR 5 years5.40%6.23%
DGR 10 years7.73%9.64%
DGR 15 years10.11%6.71%
Time since last change announced298 days
EPS growth (5y)-8.90%
EPS growth (5y forward)5.00%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM64.88%29.87%
Average--
Forward25.36%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E47.61
Price to OCF17.48
Price to FCF21.92
Price to EBITDA18.83
EV to EBITDA25.35

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.18
Price to Book3.07
EV to Sales5.63

FINANCIALS

Per share

Loading...
Per share data
Current share count290.82M
EPS (TTM)5.51
FCF per share (TTM)11.96

Income statement

Loading...
Income statement data
Revenue (TTM)18.21B
Gross profit (TTM)8.33B
Operating income (TTM)2.46B
Net income (TTM)1.60B
EPS (TTM)5.51
EPS (1y forward)13.09

Margins

Loading...
Margins data
Gross margin (TTM)45.76%
Operating margin (TTM)13.48%
Profit margin (TTM)8.79%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash3.73B
Net receivables2.12B
Total current assets10.00B
Goodwill23.77B
Intangible assets13.25B
Property, plant and equipment6.14B
Total assets54.92B
Accounts payable5.38B
Short/Current long term debt17.72B
Total current liabilities5.38B
Total liabilities30.09B
Shareholder's equity24.83B
Net tangible assets-12.20B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)4.36B
Capital expenditures (TTM)883.00M
Free cash flow (TTM)3.48B
Dividends paid (TTM)1.04B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity6.49%
Return on Assets2.92%
Return on Invested Capital3.77%
Cash Return on Invested Capital8.18%
COMPANY DETAILS
BDX (Becton, Dickinson and Company) company logo
Marketcap
76.18B
Marketcap category
Large-cap
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Employees
70000
Investor relations
SEC filings
CEO
Thomas Polen
Country
USA
City
Franklin Lakes
Stock type
Common stock
CCC status
Dividend Champion
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
September 17, 2021
If the idea that you might see a significant fraction of your portfolio's value vanish due to falling share prices is the sort of thing that can keep you up at night, you're not alone. For some peopl...
September 4, 2021
Becton, Dickinson and Company ( NYSE:BDX ) stock is about to trade ex-dividend in three days. The ex-dividend date...
September 3, 2021
In this article, we will discuss 10 stocks to invest in today according to Rob Cope’s Columbus Point. If you want to skip our detailed analysis of Rob Cope’s history, investment philosophy, and hedge ...
August 31, 2021
BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.
August 27, 2021
U.S. companies are scrambling to boost production of coronavirus tests increasingly in short supply as COVID-19 cases soar and schools and employers revive surveillance programs that will require tens...
August 26, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will present at the following upcoming virtual investor conferences:
August 26, 2021
EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.
August 26, 2021
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.
August 26, 2021
The FDA has issued an Emergency Use Authorization (EUA) for Becton Dickinson and Co's (NYSE: BDX) BD Veritor At-Home COVID-19 Test. Also Read: BD's Automated Molecular Diagnostics Platform Wins FDA Ap...
August 25, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA)...
Next page